Literature DB >> 10702711

Human cytomegalovirus reactivation in bone-marrow-derived granulocyte/monocyte progenitor cells and mature monocytes.

S Prösch1, W D Döcke, P Reinke, H D Volk, D H Krüger.   

Abstract

Monocyte/granulocyte progenitor cells of the bone marrow are a major site of human cytomegalovirus (HCMV) latency. The mechanisms of establishment and maintenance of HCMV latency are still unknown. Reactivation of the latent virus in bone-marrow-derived progenitor cells has been demonstrated in vitro and suggested to occur also in vivo. Clinical studies have shown that reactivation is a rather frequent event not only in immunosuppressed but also in nonimmunosuppressed patients and in healthy blood donors. At least three independent mechanisms of virus reactivation are discussed: systemic inflammation connected with strong tumor necrosis factor alpha release; application of cAMP-elevating drugs, and highly stressful events associated with increased plasma catecholamine levels. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10702711     DOI: 10.1159/000053965

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  15 in total

1.  Bone-marrow-derived mesenchymal stem cells as a target for cytomegalovirus infection: implications for hematopoiesis, self-renewal and differentiation potential.

Authors:  Sergey V Smirnov; Ryhor Harbacheuski; Anita Lewis-Antes; Hua Zhu; Pranela Rameshwar; Sergei V Kotenko
Journal:  Virology       Date:  2006-11-17       Impact factor: 3.616

Review 2.  BK polyomavirus infection and nephropathy: the virus-immune system interplay.

Authors:  Nina Babel; Hans-Dieter Volk; Petra Reinke
Journal:  Nat Rev Nephrol       Date:  2011-05-24       Impact factor: 28.314

3.  Circulating dendritic cells isolated from healthy seropositive donors are sites of human cytomegalovirus reactivation in vivo.

Authors:  Matthew B Reeves; John H Sinclair
Journal:  J Virol       Date:  2013-07-24       Impact factor: 5.103

4.  Alternative promoters drive human cytomegalovirus reactivation from latency.

Authors:  Donna Collins-McMillen; Mike Rak; Jason C Buehler; Suzu Igarashi-Hayes; Jeremy P Kamil; Nathaniel J Moorman; Felicia Goodrum
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-13       Impact factor: 11.205

5.  A myeloid progenitor cell line capable of supporting human cytomegalovirus latency and reactivation, resulting in infectious progeny.

Authors:  Christine M O'Connor; Eain A Murphy
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

Review 6.  The intimate relationship between human cytomegalovirus and the dendritic cell lineage.

Authors:  John Sinclair; Matthew Reeves
Journal:  Front Microbiol       Date:  2014-08-07       Impact factor: 5.640

7.  Human cytomegalovirus reactivation from latency: validation of a "switch" model in vitro.

Authors:  Maria-Cristina Arcangeletti; Rosita Vasile Simone; Isabella Rodighiero; Flora De Conto; Maria-Cristina Medici; Clara Maccari; Carlo Chezzi; Adriana Calderaro
Journal:  Virol J       Date:  2016-10-22       Impact factor: 4.099

Review 8.  Cytomegalovirus latency and reactivation: recent insights into an age old problem.

Authors:  Liane Dupont; Matthew B Reeves
Journal:  Rev Med Virol       Date:  2015-11-17       Impact factor: 6.989

9.  Age-associated increase of low-avidity cytomegalovirus-specific CD8+ T cells that re-express CD45RA.

Authors:  Stephen J Griffiths; Natalie E Riddell; Joanne Masters; Valentina Libri; Sian M Henson; Anne Wertheimer; Diana Wallace; Stuart Sims; Laura Rivino; Anis Larbi; David M Kemeny; Janko Nikolich-Zugich; Florian Kern; Paul Klenerman; Vince C Emery; Arne N Akbar
Journal:  J Immunol       Date:  2013-05-01       Impact factor: 5.422

Review 10.  Pathogenesis of human cytomegalovirus in the immunocompromised host.

Authors:  Paul Griffiths; Matthew Reeves
Journal:  Nat Rev Microbiol       Date:  2021-06-24       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.